Throughout November, December And January, All Donations Made To Parasites Without Borders Will Be Matched By PWB And Donated To MicrobeTV
February 15, 2024
Early Estimates of Nirsevimab Immunoprophylaxis Effectiveness against Hospital Admission |
Redirecting Antibody Responses from Egg-adapted Epitopes Following Repeat Vaccination |
Risk of Cardiovascular Events after Influenza | Risk of Death Following Chikungunya Virus Disease |
Comparative Effectiveness of Alternative Intervals Between First and Second Doses | Early Mortality After the First Dose of Coronavirus Disease
February 8, 2024
Estimating the Heritability of SARS-CoV-2 Susceptibility and COVID-19 Severity | Neonatal Outcomes After COVID-19 Vaccination in Pregnancy | Contralateral Second Dose Improves Antibody Responses to a Two-dose mRNA Vaccination
Regimen | Substantial Health and Economic Burden of COVID-19 During the Year After Acute Illness
Among US Adults Not at High Risk of Severe COVID-19
January 31, 2024
Efficacy and safety of respiratory syncytial virus (RSV) prefusion F protein vaccine (RSVPreF3 OA) in older adults over 2 RSV seasons | Effectiveness of High-dose vs. Standard-dose Quadrivalent Influenza Vaccine against Recurrent Hospitalizations and Mortality in Relation to Influenza Circulation: A Post-hoc Analysis of the DANFLU-1 Randomized Clinical Trial
January 25, 2024
Integrated Genomic and Social Network Analyses of Severe Acute Respiratory Syndrome
Coronavirus 2 Transmission in the Healthcare Setting | Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19 | Persistent Complement Dysregulation with Signs of Thromboinflammation in Active Long Covid
January 17, 2024
Outcomes of SARS-CoV-2 and Seasonal Viruses Among Children Hospitalized in Brazil | COVID-19 Vaccine Effectiveness Among Adolescents | Vaccine Effectiveness Against Long COVID in Children | Socioemotional Development of Infants and Toddlers During the COVID-19 Pandemic
January 11, 2024
The Death Rate of COVID-19 Infection in Different SARS-CoV-2 Variants was Related to C-reactive Protein Gene Polymorphisms | Early COVID-19 Vaccine Effectiveness of XBB.1.5 Vaccine against Hospitalization and Admission to Intensive Care, the Netherlands, 9 October to 5 December 2023
- « Anterior
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 41
- Siguiente »
Situation Dashboards
World Health Organization (WHO)
Novel Coronavirus (COVID-19) Situation from World Health Organization (WHO)
Johns Hopkins University (JHU)
Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at JHU
COVID-19 in US and Canada
1Point3Acres Real-Time Coronavirus (COVID-19) Updates in US and Canada with Credible Sources
Genomic Epidemiology COVID-19
Genomic Epidemiology of (COVID-19) Maintained by the Nextstrain team, enabled by data from GISAID.